LWA
CVS icon

Lineweaver Wealth Advisors’s CVS Health CVS Stock Holding History

Lineweaver Wealth Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-22,934
Closed -$1.83M – 129
2024
Q1 		$1.83M Buy
22,934
+1,976
+9% +$151K 0.43% 46
2023
Q4 		$1.66M Sell
20,958
-6,414
-23% -$456K 0.43% 48
2023
Q3 		$1.91M Sell
27,372
-2,786
-9% -$197K 0.56% 37
2023
Q2 		$2.09M Buy
30,158
+251
+0.8% +$17.9K 0.59% 39
2023
Q1 		$2.22M Buy
29,907
+1,921
+7% +$161K 0.68% 30
2022
Q4 		$2.61M Buy
27,986
+377
+1% +$36.4K 0.79% 28
2022
Q3 		$2.63M Buy
27,609
+16,212
+142% +$1.6M 0.85% 26
2022
Q2 		$1.06M Buy
11,397
+1,498
+15% +$146K 0.35% 54
2022
Q1 		$1M Buy
9,899
+1,284
+15% +$135K 0.29% 60
2021
Q4 		$888K Buy
8,615
+3,136
+57% +$290K 0.26% 63
2021
Q3 		$464K Buy
5,479
+1,373
+33% +$115K 0.14% 84
2021
Q2 		$342K Buy
4,106
+45
+1% +$3.69K 0.11% 92
2021
Q1 		$305K Sell
4,061
-543
-12% -$39.6K 0.11% 89
2020
Q4 		$314K Buy
4,604
+533
+13% +$34.7K 0.12% 75
2020
Q3 		$237K Buy
4,071
+569
+16% +$35.4K 0.11% 79
2020
Q2 		$227K Buy
+3,502
New +$221K 0.12% 73

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Lineweaver Wealth Advisors's CVS Position: Q2 2024 in Review

Lineweaver Wealth Advisors sold out of CVS Health (CVS) in Q2 2024, closing a stake of 22,934 shares — an estimated $1.83M sold.

Lineweaver Wealth Advisors first reported a position in CVS in Q2 2020 and held it in 16 quarters. The position peaked at $2.63M in Q3 2022. 1,914 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • Lineweaver Wealth Advisors reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • Lineweaver Wealth Advisors sold 22,934 CVS Health shares in Q2 2024, an estimated $1.83M.
  • Lineweaver Wealth Advisors first reported a position in CVS Health in Q2 2020 and held it in 16 quarters.
  • Lineweaver Wealth Advisors's CVS Health position peaked at $2.63M in Q3 2022.
  • 1,914 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Lineweaver Wealth Advisors's 13F filing for Q2 2024, filed 2 Aug 2024.